These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2687423)

  • 21. Comparative trial of pinacidil versus prazosin in mild to moderate arterial hypertension.
    Sterndorff B; Johansen P
    Drugs; 1988; 36 Suppl 7():64-6. PubMed ID: 3076137
    [No Abstract]   [Full Text] [Related]  

  • 22. A randomized, controlled, multicenter study to compare prazosin GITS with enalapril in hypertensive patients with diabetes mellitus. Bombay Hypertension Study Group.
    Joglekar SJ; Nanivadekar AS
    J Assoc Physicians India; 1998; Suppl 1():52-62. PubMed ID: 11233387
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of prazosin and propranolol on serum lipids in patients with essential hypertension.
    Lowenstein J; Neusy AJ
    Am J Med; 1984 Feb; 76(2A):79-84. PubMed ID: 6702864
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of trimazosin on serum lipid profiles in hypertensive patients.
    Singleton W; Taylor CR
    Am Heart J; 1983 Nov; 106(5 Pt 2):1265-8. PubMed ID: 6356856
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the effects of prazosin versus propranolol on plasma lipoprotein lipids in patients receiving hemodialysis.
    Harter HR; Meltzer VN; Tindira CA; Naumovich AD; Goldberg AP
    Am J Med; 1986 Feb; 80(2A):82-9. PubMed ID: 3511693
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dose-effect and concentration-effect relationships of pinacidil and hydrochlorothiazide in hypertension.
    Goldberg MR; Rockhold FW; Offen WW; Dornseif BE
    Clin Pharmacol Ther; 1989 Aug; 46(2):208-18. PubMed ID: 2758730
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the effects of guanabenz and hydrochlorothiazide on plasma lipids.
    Kaplan NM; Grundy S
    Clin Pharmacol Ther; 1988 Sep; 44(3):297-302. PubMed ID: 3046814
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of alpha- and beta-blocker therapy on blood lipids: European experience.
    Leren P
    Am J Med; 1984 Feb; 76(2A):67-71. PubMed ID: 6142644
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A double-blind, randomized, controlled trial comparing pinacidil to hydralazine in essential hypertension.
    Byyny RL; Nies AS; LoVerde ME; Mitchell WD
    Clin Pharmacol Ther; 1987 Jul; 42(1):50-7. PubMed ID: 3297468
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prazosin improves atherogenic index and inhibits the deleterious effect of dihydrochlorothiazide in patients with essential hypertension.
    Farsang C; Péter M; Balás-Eltes A; Fehér J
    J Cardiovasc Pharmacol; 1987; 10 Suppl 12():S240-3. PubMed ID: 2455187
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of pinacidil on serum lipid, lipoprotein, and apolipoprotein levels in patients with mild to moderate hypertension.
    Saku K; Ying H; Arakawa K
    Clin Ther; 1990; 12(2):132-8. PubMed ID: 2354482
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acifran: a double-blind, randomized, placebo-controlled efficacy study in type IIa hyperlipoproteinemic patients.
    LaRosa JC; Miller VT; Edwards KD; DeBovis MR; Stoy DB
    Artery; 1987; 14(6):338-50. PubMed ID: 3314798
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prazosin versus hydrochlorothiazide as initial antihypertensive therapy in black versus white patients.
    Batey DM; Nicolich MJ; Lasser VI; Jeffrey SS; Lasser NL
    Am J Med; 1989 Jan; 86(1B):74-8. PubMed ID: 2643866
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Prazosin in the treatment of hypertension: effect on lipid metabolism].
    Hitzenberger G; Neumann K; Dietz S; Egger H; Hariri K; Kittler E; Niedrist W; Nitsch-Fritz R; Ravanelli O; Sapinsky H
    Wien Med Wochenschr; 1987 Nov; 137(22):525-30. PubMed ID: 3433787
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Studies on the effect of prazosin on blood pressure and serum lipids in Japanese hypertensive patients.
    Saruta T
    Am J Med; 1984 Feb; 76(2A):117-21. PubMed ID: 6367447
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative effects of pinacidil and nifedipine in the treatment of arterial hypertension.
    Jürgensen HJ
    Drugs; 1988; 36 Suppl 7():67-9. PubMed ID: 3076138
    [No Abstract]   [Full Text] [Related]  

  • 37. Comparative effects of 10-mg versus 80-mg Atorvastatin on high-sensitivity C-reactive protein in patients with stable coronary artery disease: results of the CAP (Comparative Atorvastatin Pleiotropic effects) study.
    Bonnet J; McPherson R; Tedgui A; Simoneau D; Nozza A; Martineau P; Davignon J;
    Clin Ther; 2008 Dec; 30(12):2298-313. PubMed ID: 19167589
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alpha 1-adrenoreceptor blockade and the molecular basis of lipid metabolism alterations.
    Pool JL; Lenz ML; Taylor AA
    J Hum Hypertens; 1990 Oct; 4 Suppl 3():23-33. PubMed ID: 1979819
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease.
    Frick MH; Elo O; Haapa K; Heinonen OP; Heinsalmi P; Helo P; Huttunen JK; Kaitaniemi P; Koskinen P; Manninen V
    N Engl J Med; 1987 Nov; 317(20):1237-45. PubMed ID: 3313041
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in serum lipid levels during antihypertensive therapy.
    Med J Aust; 1984 Apr; 140(9):522-4. PubMed ID: 6369095
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.